Therapeutic Drug Monitoring in Crohn's Disease

This fast-paced symposium, led by Dr. William Sandborn, will be a vital update on the role of therapeutic drug monitoring to optimize management plans for Crohn’s disease.

The faculty will review the evidence for TPMP-guided initiation of thiopurines and therapeutic drug monitoring in patients receiving longer term therapy. The role of pharmacokinetic/pharmacodynamics assessment in patients receiving anti-TNF therapy will also be discussed, including important new evidence from long-term trials.

This program includes opportunity for discussion so that you can fully consider the clinical implementation of these strategies.

IBD Working Group

The mission of the Inflammatory Bowel Disease Working Group (IBDWG) is to provide a forum for the education of healthcare professionals through the development and exchange of high-quality evidence-based materials which are easily accessible and which aim to improve the quality-of-life of patients with inflammatory bowel disease.